Haladhar Dev Sarma
-
- Radiopharmaceutical Chemistry and Applications 187
- Medical Imaging Techniques and Applications 82
- Monoclonal and Polyclonal Antibodies Research 22
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery 16
-
- Medical Imaging and Pathology Studies 53
- Oncology top 5%
- Peptidase Inhibition and Analysis 35
- Cancer Research top 10%
-
- Neuroendocrine Tumor Research Advances 23
-
- Orthopaedic implants and arthroplasty 16
- Co-authors
- Sharmila BanerjeeTapas DasSudipta ChakrabortyMeera VenkateshAshutosh DashGrace SamuelM.R.A. PillaiMadhava B. Mallia
- Journals
- Nuclear Medicine and Biology (29 papers)Applied Radiation and Isotopes (28 papers)Cancer Biotherapy and Radiopharmaceuticals (25 papers)
- Partner nations
- IndiaUnited StatesAustralia
In The Last Decade
Haladhar Dev Sarma
252 papers receiving 3.4k citations
Peers
Comparison fields: 5 of 130
- Radiology, Nuclear Medicine and Imaging 2.0k
- Biomaterials 436
- Pulmonary and Respiratory Medicine 861
- Oncology 692
- Cancer Research 270
Countries citing papers authored by Haladhar Dev Sarma
This map shows the geographic impact of Haladhar Dev Sarma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haladhar Dev Sarma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haladhar Dev Sarma more than expected).
Fields of papers citing papers by Haladhar Dev Sarma
This network shows the impact of papers produced by Haladhar Dev Sarma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haladhar Dev Sarma. The network helps show where Haladhar Dev Sarma may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Haladhar Dev Sarma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 1 | |
| 4 | 2023 | 2 | |
| 5 | 2022 | 7 | |
| 6 | 2021 | 17 | |
| 7 | 2020 | 11 | |
| 8 | 2019 | 5 | |
| 9 | 2019 | 3 | |
| 10 | 2018 | 8 | |
| 11 | 2018 | 2 | |
| 12 | 2018 | 4 | |
| 13 | Synthesis and evaluation of a novel 68Ga-NODAGA-Erlotinib analogue towards PET imaging of Epidermal Growth Factor Receptor over-expressing cancers | 2018 | 4 |
| 14 | 2017 | 5 | |
| 15 | 2017 | 5 | |
| 16 | 2017 | 4 | |
| 17 | Effect of strategic feed supplementation on growth performance and nutrient utilization in yak calves during winter | 2012 | 4 |
| 18 | 2012 | 11 | |
| 19 | 2010 | 5 | |
| 20 | 2010 | 25 |
About Haladhar Dev Sarma
Haladhar Dev Sarma is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Pulmonary and Respiratory Medicine, having authored 255 papers that have together received 3.5k indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (187 papers), Medical Imaging Techniques and Applications (82 papers), Medical Imaging and Pathology Studies (53 papers), Peptidase Inhibition and Analysis (35 papers), Neuroendocrine Tumor Research Advances (23 papers), Monoclonal and Polyclonal Antibodies Research (22 papers), Nanoparticle-Based Drug Delivery (16 papers) and Orthopaedic implants and arthroplasty (16 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (2.0k citations), Biomaterials (436 citations) and Pulmonary and Respiratory Medicine (861 citations). Haladhar Dev Sarma has collaborated with scholars based in India, United States and Australia. Frequent co-authors include Sharmila Banerjee, Tapas Das, Sudipta Chakraborty, Meera Venkatesh, Ashutosh Dash, Grace Samuel, M.R.A. Pillai, Madhava B. Mallia, Usha Pandey and Anupam Mathur. Their work appears in journals such as Nuclear Medicine and Biology, Applied Radiation and Isotopes, Cancer Biotherapy and Radiopharmaceuticals, Journal of Radioanalytical and Nuclear Chemistry and Nuclear Medicine Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.